Drugs / PlexoZome® Levagen®
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT06351917 | Apr → Jun 2024 | osteoarthritis, knee | RDC Clinical Pty Ltd | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PlexoZome Levagen | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06351917 ↗ |
| Route | Topical | “PlexoZome® Levagen® topical spray solution applied as 3 full pumps on the affected knee area” NCT06351917 ↗ |